Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Persons With Celiac Disease Age > 10 Years

NCT03707730 is registered in ClinicalTrials.gov with Igy Inc. as lead sponsor.

NCT NCT03707730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03707730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Persons With Celiac Disease Age > 10 Years
Lead sponsor
Igy Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 29, 2019
Completion date
December 31, 2023
Enrollment
161 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease